Neurocrine Biosciences· @neurocrine · X·· 15 天前AI 评分22
AI 导读
我们的 2026 年第三季度业绩反映了持续的势头,我们在此基础上继续推进进展,践行使命,为需求迫切的患者带来改变生活的治疗方案。 在此阅读新闻稿:https://neurocrine.gcs-web.com/news-releases/news-release-details/neurocrine-biosciences-reports-third-quarter-2026-financial-0
正文
Our third-quarter 2026 results reflect continued momentum as we build on our progress and advance our mission to bring life-changing treatments to patients with great needs.
Read the news release here: https://neurocrine.gcs-web.com/news-releases/news-release-details/neurocrine-biosciences-reports-third-quarter-2026-financial-0
来源:Neurocrine Biosciences · x.com